Reaction Details |
| Report a problem with these data |
Target | 5-hydroxytryptamine receptor 1A |
---|
Ligand | BDBM50186236 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_370314 (CHEMBL868481) |
---|
Ki | 15±n/a nM |
---|
Citation | Zajdel, P; Subra, G; Bojarski, AJ; Duszynska, B; Pawlowski, M; Martinez, J Arylpiperazines with N-acylated amino acids as 5-HT1A receptor ligands. Bioorg Med Chem Lett16:3406-10 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
5-hydroxytryptamine receptor 1A |
---|
Name: | 5-hydroxytryptamine receptor 1A |
Synonyms: | 5-HT-1A | 5-HT1A | 5-hydroxytryptamine receptor 1A (5-HT-1A) | 5HT1A_HUMAN | ADRB2RL1 | ADRBRL1 | Dopamine D2 receptor and serotonin 1a receptor | G-21 | HTR1A | Serotonin receptor 1A |
Type: | n/a |
Mol. Mass.: | 46122.49 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 422 |
Sequence: | MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAA
IALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCC
TSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPED
RSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADT
RHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGN
SKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLP
FFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFC
RQ
|
|
|
BDBM50186236 |
---|
n/a |
---|
Name | BDBM50186236 |
Synonyms: | Adamantane-1-carboxylic acid ((S)-1-{4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-butyl}-2,5-dioxo-pyrrolidin-3-yl)-amide | CHEMBL208905 | N-((S)-1-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}pyrrolidin-2,5-dion-yl)-1-adamantanecarboxamide | N-[(3S)-1-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}-2,5-dioxopyrrolidin-3-yl]adamantane-1-carboxamide |
Type | Small organic molecule |
Emp. Form. | C30H42N4O4 |
Mol. Mass. | 522.6789 |
SMILES | COc1ccccc1N1CCN(CCCCN2C(=O)C[C@H](NC(=O)C34CC5CC(CC(C5)C3)C4)C2=O)CC1 |r,TLB:22:24:27.26.31:29,THB:25:26:29:33.24.32,25:24:27.26.31:29,32:24:27:31.30.29,32:30:27:33.25.24| |
Structure |
|